The immunohistochemistry (ihc) market size has grown rapidly in recent years. It will grow from $2.76 billion in 2025 to $3.05 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to growing use of ihc in cancer diagnostics, expansion of hospital pathology laboratories, increased availability of monoclonal antibodies, rising adoption of tissue-based diagnostics, growing clinical research activities.
The immunohistochemistry (ihc) market size is expected to see rapid growth in the next few years. It will grow to $4.47 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing demand for precision oncology diagnostics, rising adoption of ai-enabled pathology analysis, expansion of biomarker-driven drug development, growing use of multiplex tissue profiling, increasing investments in advanced pathology infrastructure. Major trends in the forecast period include increasing adoption of automated ihc staining systems, rising use of multiplex ihc techniques, growing integration of digital pathology platforms, expansion of companion diagnostic applications, enhanced focus on high-specificity antibodies.
The increasing demand for personalized medicines is anticipated to accelerate the growth of the immunohistochemistry (IHC) market in the coming years. Personalized medicine refers to a healthcare approach that customizes medical decisions, treatments, and products to individual patients based on their genetic makeup, environmental factors, and lifestyle attributes. Immunohistochemistry plays a crucial role in this approach by enabling the identification of specific protein biomarkers that support precise tumor classification and accurate diagnosis. For example, in February 2024, according to the Personalized Medicine Coalition, a United States-based non-profit research organization, personalized medicines represented more than one-third of all new approvals by the United States Food and Drug Administration in 2023. During the same year, the FDA approved 16 new personalized therapies for rare disease patients, compared to six approvals in 2022. As a result, the rising adoption of personalized medicines is contributing to the expansion of the immunohistochemistry market.
Major players in the immunohistochemistry (IHC) market are concentrating on improving diagnostic accuracy through innovative technologies and high-quality reagents to enhance tissue analysis effectiveness in various clinical and research contexts. The Neoflex multiomics mass spectrometry imaging (MSI) system is a cutting-edge imaging platform tailored for precise tissue analysis, enabling researchers to progress from discovery to clinical applications using high-resolution mass spectrometry techniques, especially for spatially mapping biomolecules in tissues. For example, in June 2024, Bruker Corporation, a US-based company that develops and manufactures scientific instruments along with analytical and diagnostic solutions, introduced its matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF/TOF) Neoflex Imaging Profiler for mass spectrometry-based tissue imaging. The Neoflex MSI system addresses the demand for advancing from discovery imaging to clinical tissue research. It incorporates Bruker's 10-kHz smartbeam 3D laser, improved imaging detectors, and supports OME-TIFF file output with SCiLS Scope software.
In December 2023, Danaher Corporation, a United States-based life sciences and diagnostics company, acquired Abcam plc for an undisclosed value. Through this acquisition, Danaher sought to broaden its portfolio of life science reagents and consumables, strengthen its protein analysis tools for both research and diagnostic applications, accelerate growth across the life sciences ecosystem, and enhance its global presence by offering more integrated solutions to researchers and healthcare professionals. Abcam plc is a United Kingdom-based biotechnology company specializing in antibodies, reagents, assays, and immunohistochemistry products.
Major companies operating in the immunohistochemistry (ihc) market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., PHC Holdings Corporation, Leica Biosystems, Vector Laboratories, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited, LifeSpan BioSciences Inc., Enzo Life Sciences Inc., Epitomics Inc., GenScript Biotech.
North America was the largest region in the immunohistochemistry (IHC) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (ihc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the immunohistochemistry (ihc) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the immunohistochemistry market by increasing costs of imported antibodies, reagents, staining systems, slide scanners, and imaging components used in diagnostic and research workflows. Hospitals and diagnostic laboratories in North America and Europe are most affected due to dependence on imported high-quality antibodies and equipment, while Asia-Pacific faces cost pressures in reagent exports. These tariffs are raising operational costs and delaying equipment upgrades. However, they are also supporting local antibody production, regional reagent manufacturing, and domestic development of automated IHC systems.
The immunohistochemistry (ihc) market research report is one of a series of new reports that provides immunohistochemistry (ihc) market statistics, including immunohistochemistry (ihc) industry global market size, regional shares, competitors with a immunohistochemistry (ihc) market share, detailed immunohistochemistry (ihc) market segments, market trends and opportunities, and any further data you may need to thrive in the immunohistochemistry (ihc) industry. This immunohistochemistry (ihc) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Immunohistochemistry (IHC) is a diagnostic technique that utilizes the interaction between antibodies and antigens to identify specific proteins and antigens within tissue sections. This interaction is visualized through chromogenic detection using enzyme-substrate or fluorescent detection using fluorescent dyes.
The main products associated with immunohistochemistry (IHC) include antibodies, equipment, reagents, and kits. Antibodies are proteins produced by the immune system to neutralize harmful antigens, and in the context of IHC, they are employed to detect the specific location of proteins or antigens for diagnostic purposes. The applications of IHC span diagnostics, drug testing, and other related areas, with end-users including hospitals, diagnostic laboratories, research institutes, and others.
The immunohistochemistry (IHC) market consists of sales of primary antibodies, slide staining system, tissue microarrays, tissue processing systems, slide scanners secondary antibodies, histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents and stabilizers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The immunohistochemistry (ihc) market size is expected to see rapid growth in the next few years. It will grow to $4.47 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing demand for precision oncology diagnostics, rising adoption of ai-enabled pathology analysis, expansion of biomarker-driven drug development, growing use of multiplex tissue profiling, increasing investments in advanced pathology infrastructure. Major trends in the forecast period include increasing adoption of automated ihc staining systems, rising use of multiplex ihc techniques, growing integration of digital pathology platforms, expansion of companion diagnostic applications, enhanced focus on high-specificity antibodies.
The increasing demand for personalized medicines is anticipated to accelerate the growth of the immunohistochemistry (IHC) market in the coming years. Personalized medicine refers to a healthcare approach that customizes medical decisions, treatments, and products to individual patients based on their genetic makeup, environmental factors, and lifestyle attributes. Immunohistochemistry plays a crucial role in this approach by enabling the identification of specific protein biomarkers that support precise tumor classification and accurate diagnosis. For example, in February 2024, according to the Personalized Medicine Coalition, a United States-based non-profit research organization, personalized medicines represented more than one-third of all new approvals by the United States Food and Drug Administration in 2023. During the same year, the FDA approved 16 new personalized therapies for rare disease patients, compared to six approvals in 2022. As a result, the rising adoption of personalized medicines is contributing to the expansion of the immunohistochemistry market.
Major players in the immunohistochemistry (IHC) market are concentrating on improving diagnostic accuracy through innovative technologies and high-quality reagents to enhance tissue analysis effectiveness in various clinical and research contexts. The Neoflex multiomics mass spectrometry imaging (MSI) system is a cutting-edge imaging platform tailored for precise tissue analysis, enabling researchers to progress from discovery to clinical applications using high-resolution mass spectrometry techniques, especially for spatially mapping biomolecules in tissues. For example, in June 2024, Bruker Corporation, a US-based company that develops and manufactures scientific instruments along with analytical and diagnostic solutions, introduced its matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF/TOF) Neoflex Imaging Profiler for mass spectrometry-based tissue imaging. The Neoflex MSI system addresses the demand for advancing from discovery imaging to clinical tissue research. It incorporates Bruker's 10-kHz smartbeam 3D laser, improved imaging detectors, and supports OME-TIFF file output with SCiLS Scope software.
In December 2023, Danaher Corporation, a United States-based life sciences and diagnostics company, acquired Abcam plc for an undisclosed value. Through this acquisition, Danaher sought to broaden its portfolio of life science reagents and consumables, strengthen its protein analysis tools for both research and diagnostic applications, accelerate growth across the life sciences ecosystem, and enhance its global presence by offering more integrated solutions to researchers and healthcare professionals. Abcam plc is a United Kingdom-based biotechnology company specializing in antibodies, reagents, assays, and immunohistochemistry products.
Major companies operating in the immunohistochemistry (ihc) market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., PHC Holdings Corporation, Leica Biosystems, Vector Laboratories, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited, LifeSpan BioSciences Inc., Enzo Life Sciences Inc., Epitomics Inc., GenScript Biotech.
North America was the largest region in the immunohistochemistry (IHC) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (ihc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the immunohistochemistry (ihc) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the immunohistochemistry market by increasing costs of imported antibodies, reagents, staining systems, slide scanners, and imaging components used in diagnostic and research workflows. Hospitals and diagnostic laboratories in North America and Europe are most affected due to dependence on imported high-quality antibodies and equipment, while Asia-Pacific faces cost pressures in reagent exports. These tariffs are raising operational costs and delaying equipment upgrades. However, they are also supporting local antibody production, regional reagent manufacturing, and domestic development of automated IHC systems.
The immunohistochemistry (ihc) market research report is one of a series of new reports that provides immunohistochemistry (ihc) market statistics, including immunohistochemistry (ihc) industry global market size, regional shares, competitors with a immunohistochemistry (ihc) market share, detailed immunohistochemistry (ihc) market segments, market trends and opportunities, and any further data you may need to thrive in the immunohistochemistry (ihc) industry. This immunohistochemistry (ihc) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Immunohistochemistry (IHC) is a diagnostic technique that utilizes the interaction between antibodies and antigens to identify specific proteins and antigens within tissue sections. This interaction is visualized through chromogenic detection using enzyme-substrate or fluorescent detection using fluorescent dyes.
The main products associated with immunohistochemistry (IHC) include antibodies, equipment, reagents, and kits. Antibodies are proteins produced by the immune system to neutralize harmful antigens, and in the context of IHC, they are employed to detect the specific location of proteins or antigens for diagnostic purposes. The applications of IHC span diagnostics, drug testing, and other related areas, with end-users including hospitals, diagnostic laboratories, research institutes, and others.
The immunohistochemistry (IHC) market consists of sales of primary antibodies, slide staining system, tissue microarrays, tissue processing systems, slide scanners secondary antibodies, histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents and stabilizers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Immunohistochemistry (IHC) Market Characteristics
3. Immunohistochemistry (IHC) Market Supply Chain Analysis
4. Global Immunohistochemistry (IHC) Market Trends and Strategies
5. Immunohistochemistry (IHC) Market Analysis of End Use Industries
7. Global Immunohistochemistry (IHC) Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Immunohistochemistry (IHC) Total Addressable Market (TAM) Analysis for the Market
9. Immunohistochemistry (IHC) Market Segmentation
10. Immunohistochemistry (IHC) Market Regional and Country Analysis
11. Asia-Pacific Immunohistochemistry (IHC) Market
12. China Immunohistochemistry (IHC) Market
13. India Immunohistochemistry (IHC) Market
14. Japan Immunohistochemistry (IHC) Market
15. Australia Immunohistochemistry (IHC) Market
16. Indonesia Immunohistochemistry (IHC) Market
17. South Korea Immunohistochemistry (IHC) Market
18. Taiwan Immunohistochemistry (IHC) Market
19. South East Asia Immunohistochemistry (IHC) Market
20. Western Europe Immunohistochemistry (IHC) Market
21. UK Immunohistochemistry (IHC) Market
22. Germany Immunohistochemistry (IHC) Market
23. France Immunohistochemistry (IHC) Market
24. Italy Immunohistochemistry (IHC) Market
25. Spain Immunohistochemistry (IHC) Market
26. Eastern Europe Immunohistochemistry (IHC) Market
27. Russia Immunohistochemistry (IHC) Market
28. North America Immunohistochemistry (IHC) Market
29. USA Immunohistochemistry (IHC) Market
30. Canada Immunohistochemistry (IHC) Market
31. South America Immunohistochemistry (IHC) Market
32. Brazil Immunohistochemistry (IHC) Market
33. Middle East Immunohistochemistry (IHC) Market
34. Africa Immunohistochemistry (IHC) Market
36. Immunohistochemistry (IHC) Market Competitive Landscape and Company Profiles
37. Immunohistochemistry (IHC) Market Other Major and Innovative Companies
40. Immunohistochemistry (IHC) Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Immunohistochemistry (IHC) Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses immunohistochemistry (ihc) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for immunohistochemistry (ihc)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immunohistochemistry (ihc) market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Antibodies; Equipment; Reagents; Kits2) By Applications: Diagnostics; Drug Testing; Other Applications
3) By End-Users: Hospitals And Diagnostic Laboratories; Research Institutes; Other End-Users
Subsegments:
1) By Antibodies: Primary Antibodies; Secondary Antibodies; Conjugated Antibodies2) By Equipment: IHC Staining Systems; Slide Scanners; Microscopes
3) By Reagents: Detection Reagents; Blocking Reagents; Mounting Media
4) By Kits: Pre-prepared IHC Kits; Multiplex IHC Kits; Specialty Kits
Companies Mentioned: Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche AG; Merck Group; Danaher Corporation; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; Cell Signaling Technology Inc.; Bio SB Inc.; Agilent Technologies Inc.; Abcam plc; Takara Bio Inc.; Biocare Medical LLC; Bio-Genex Laboratories; Diagnostic BioSystems Inc.; PHC Holdings Corporation; Leica Biosystems; Vector Laboratories; Ionpath Inc.; Reveal Biosciences; Akrivis Technologies Private Limited; LifeSpan BioSciences Inc.; Enzo Life Sciences Inc.; Epitomics Inc.; GenScript Biotech
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Immunohistochemistry (IHC) market report include:- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche AG
- Merck Group
- Danaher Corporation
- PerkinElmer Inc.
- Bio-Rad Laboratories Inc.
- Cell Signaling Technology Inc.
- Bio SB Inc.
- Agilent Technologies Inc.
- Abcam plc
- Takara Bio Inc.
- Biocare Medical LLC
- Bio-Genex Laboratories
- Diagnostic BioSystems Inc.
- PHC Holdings Corporation
- Leica Biosystems
- Vector Laboratories
- Ionpath Inc.
- Reveal Biosciences
- Akrivis Technologies Private Limited
- LifeSpan BioSciences Inc.
- Enzo Life Sciences Inc.
- Epitomics Inc.
- GenScript Biotech
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.05 Billion |
| Forecasted Market Value ( USD | $ 4.47 Billion |
| Compound Annual Growth Rate | 10.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
